Abstract:Individualized treatment rules can improve health outcomes by recognizing that patients may respond differently to treatment and assigning therapy with the most desirable predicted outcome for each individual. Flexible and efficient prediction models are desired as a basis for such individualized treatment rules to handle potentially complex interactions between patient factors and treatment. Modern Bayesian semiparametric and nonparametric regression models provide an attractive avenue in this regard as these allow natural posterior uncertainty quantification of patient specific treatment decisions as well as the population wide value of the prediction-based individualized treatment rule. In addition, via the use of such models, inference is also available for the value of the optimal individualized treatment rules. We propose such an approach and implement it using Bayesian Additive Regression Trees as this model has been shown to perform well in fitting nonparametric regression functions to continuous and binary responses, even with many covariates. It is also computationally efficient for use in practice. With Bayesian Additive Regression Trees, we investigate a treatment strategy which utilizes individualized predictions of patient outcomes from Bayesian Additive Regression Trees models. Posterior distributions of patient outcomes under each treatment are used to assign the treatment that maximizes the expected posterior utility. We also describe how to approximate such a treatment policy with a clinically interpretable individualized treatment rule, and quantify its expected outcome. The proposed method performs very well in extensive simulation studies in comparison with several existing methods. We illustrate the usage of the proposed method to identify an individualized choice of conditioning regimen for patients undergoing hematopoietic cell transplantation and quantify the value of this method of choice in relation to the optimal individualized treatment rule as well as non-individualized treatment strategies.

PSICA: Decision trees for probabilistic subgroup identification with categorical treatments

Subgroup identification in clinical trials: an overview of available methods and their implementations with R

Subgroup Identification Using the personalized Package

A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data

Detecting treatment-subgroup interactions in clustered data with generalized linear mixed-effects model trees

Subgroup Identification using Covariate Adjusted Interaction Trees

Decision making and uncertainty quantification for individualized treatments using Bayesian Additive Regression Trees

Identifying treatment response subgroups in observational time-to-event data

Statistical Performance Guarantee for Subgroup Identification with Generic Machine Learning

Model-based Recursive Partitioning for Subgroup Analyses

Recovering Sparse and Interpretable Subgroups with Heterogeneous Treatment Effects with Censored Time-to-Event Outcomes

Exploring Heterogeneity in Clinical Trials with Latent Class Analysis

Personalized treatment selection via product partition models with covariates

Selecting optimal subgroups for treatment using many covariates

SUBIC: A Supervised Bi-Clustering Approach for Precision Medicine

Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation

Iterative Causal Forest: A Novel Algorithm for Subgroup Identification.

Probabilistic learning of treatment trees in cancer

Decision Theory for Treatment Choice Problems with Partial Identification

Mining Heterogeneous Causal Effects for Personalized Cancer Treatment.

Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials